Actinium Pharmaceuticals Inc (ATNM)
1.76
+0.05
(+2.92%)
USD |
NYAM |
Nov 04, 16:00
1.75
-0.01
(-0.57%)
Pre-Market: 20:00
Actinium Pharmaceuticals Price to Book Value: 1.251 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.251 |
| November 01, 2024 | 1.215 |
| October 31, 2024 | 1.279 |
| October 30, 2024 | 1.265 |
| October 29, 2024 | 1.336 |
| October 28, 2024 | 1.301 |
| October 25, 2024 | 1.194 |
| October 24, 2024 | 1.194 |
| October 23, 2024 | 1.279 |
| October 22, 2024 | 1.336 |
| October 21, 2024 | 1.265 |
| October 18, 2024 | 1.294 |
| October 17, 2024 | 1.222 |
| October 16, 2024 | 1.194 |
| October 15, 2024 | 1.244 |
| October 14, 2024 | 1.251 |
| October 11, 2024 | 1.279 |
| October 10, 2024 | 1.158 |
| October 09, 2024 | 1.123 |
| October 08, 2024 | 1.158 |
| October 07, 2024 | 1.180 |
| October 04, 2024 | 1.272 |
| October 03, 2024 | 1.265 |
| October 02, 2024 | 1.350 |
| October 01, 2024 | 1.294 |
| Date | Value |
|---|---|
| September 30, 2024 | 1.336 |
| September 27, 2024 | 1.279 |
| September 26, 2024 | 1.272 |
| September 25, 2024 | 1.279 |
| September 24, 2024 | 1.286 |
| September 23, 2024 | 1.308 |
| September 20, 2024 | 1.279 |
| September 19, 2024 | 1.336 |
| September 18, 2024 | 1.265 |
| September 17, 2024 | 1.294 |
| September 16, 2024 | 1.258 |
| September 13, 2024 | 1.322 |
| September 12, 2024 | 1.393 |
| September 11, 2024 | 1.386 |
| September 10, 2024 | 1.336 |
| September 09, 2024 | 1.301 |
| September 06, 2024 | 1.265 |
| September 05, 2024 | 1.222 |
| September 04, 2024 | 1.279 |
| September 03, 2024 | 1.329 |
| August 30, 2024 | 1.414 |
| August 29, 2024 | 1.358 |
| August 28, 2024 | 1.350 |
| August 27, 2024 | 1.414 |
| August 26, 2024 | 1.500 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.123
Minimum
Oct 09 2024
57.57
Maximum
Jun 22 2020
4.295
Average
3.144
Median
Price to Book Value Benchmarks
| Rezolute Inc | 2.480 |
| Moderna Inc | 1.757 |
| Perspective Therapeutics Inc | 2.410 |
| Eli Lilly and Co | 53.74 |
| Cellectar Biosciences Inc | 18.15 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0286 |
| Price | 1.76 |
| Earnings Yield | -85.80% |
| Market Cap | 54.83M |
| PEGY Ratio | -0.0286 |